Table 1.
Clinical characteristics of 77 patients in this study.
| Arm 1 (n = 27) | Arm 2 (n = 50) | P value | |
|---|---|---|---|
| Sex | |||
| Male | 12 | 29 | 0.255 |
| Female | 15 | 21 | |
| Age (year) | |||
| >60 | 11 | 21 | 0.915 |
| ≤60 | 16 | 29 | |
| KPS | |||
| ≥80 | 22 | 45 | 0.289 |
| <80 | 5 | 5 | |
| Primary tumor site | |||
| Mucosa type∗ | 4 | 15 | 0.140 |
| No-mucosa type∗ | 23 | 35 | |
| R-CIK | |||
| Yes | 22 | 45 | 0.289 |
| No | 5 | 5 | |
| Treatment after metastasis | |||
| Surgical | 8 | 10 | — |
| Immunotherapy | 27 | 45 | — |
| Chemotherapy | 5 | 10 | — |
| Radiotherapy | 3 | 6 | — |
| Any 2 or more | 16 | 35 | — |
| Any 3 or more | 3 | 8 | 0.912 |
∗In Arm 1, mucosa type patients include 3 patients with nasal cavity mucosa melanoma and one patient with mouth cavity melanoma. No-mucosa type patients include 12 patients with acral lentiginous melanoma, 7 patients with nodular melanoma, and 4 patients with superficial spreading melanoma. In Arm 2, mucosa type patients include 5 patients with rectal mucosa melanoma, 6 patients with nasal cavity mucosa melanoma, 2 patients with mouth cavity melanoma, one patient with penis mucosa melanoma, and one patient with vaginal mucosa melanoma. No-mucosa type patients include 14 patients with acral lentiginous melanoma, 11 patients with nodular melanoma, and 10 patients with superficial spreading melanoma.